Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs

被引:25
|
作者
Kantathavorn, Nuttavut [1 ,4 ]
Mahidol, Chulabhorn [1 ,2 ,3 ]
Sritana, Narongrit [1 ]
Sricharunrat, Thaniya [1 ]
Phoolcharoen, Natacha [1 ,4 ]
Auewarakul, Chirayu [1 ,3 ]
Teerayathanakul, Narongchai [1 ]
Taepisitpong, Chantanee [1 ]
Saeloo, Siriporn [1 ]
Sornsamdang, Gaidganok [1 ]
Udomchaiprasertkul, Wandee [1 ]
Krongthong, Waraphorn [1 ]
Arnamwong, Arpaporn [1 ]
机构
[1] Chulabhorn Hosp, Bangkok, Thailand
[2] Chulabhorn Res Inst, Bangkok, Thailand
[3] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand
[4] Chulabhorn Hosp, Gynecol Oncol Unit, Bangkok 10210, Thailand
来源
INFECTIOUS AGENTS AND CANCER | 2015年 / 10卷
关键词
Cervical cancer; Cancer screening; HPV genotypes; Cervical cytology; Thailand; PREVALENCE; INFECTION; VACCINATION; DNA; PROVINCE;
D O I
10.1186/s13027-015-0001-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cervical cancer is the major cause of morbidity and mortality in Thai women. Nevertheless, the preventive strategy such as HPV vaccination program has not been implemented at the national level. This study explored the HPV prevalence and genotypic distribution in a large cohort of Thai women. Methods: A hospital-based cervical cancer screening program at Chulabhorn Hospital, Bangkok and a population-based screening program at a rural Pathum Thani Province were conducted using liquid-based cytology and HPV genotyping. Results: Of 5906 women aged 20-70 years, Pap smear was abnormal in 4.9% and the overall HPV prevalence was 15.1%, with 6.4% high-risk (HR), 3.5% probable high-risk (PR), and 8.4% low-risk (LR) HPV. The prevalence and genotypic distribution were not significantly different between the two cohorts. Among HR-HPV genotypes, HPV52 was the most frequent (1.6%), followed by HPV16 (1.4%), HPV51 (0.9%), HPV58 (0.8%), HPV18 (0.6%), and HPV39 (0.6%). Among LR-HPV genotypes, HPV72 and HPV62 were the most frequent while HPV6 and HPV11 were rare. HPV infection was found to be proportionately high in young women, aged 20-30 years (25%) and decreasing with age (11% in women aged > 50). The more severe abnormal cytology results, the higher positivity of HR-HPV infection was observed. Conclusions: In conclusion, HPV52, HPV16, and HPV51 were identified as the most common HR-HPV genotypes in Thai women. This study contributes genotypic evidence that should be essential for the development of appropriate HPV vaccination program as part of Thailand's cervical cancer prevention strategies.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Prevalence and Type Distribution of High-Risk Human Papillomavirus Infection in Women Undergoing Voluntary Cervical Cancer Screening in Italy
    Agarossi, Alberto
    Ferrazzi, Enrico
    Parazzini, Fabio
    Perno, Carlo Federico
    Ghisoni, Luciano
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (03) : 529 - 535
  • [42] Cytology Triage for HPV-Positive Postmenopausal Women in a Setting of Cervical Cancer Screening
    Chacko, Aparna
    Bidkar, Vishaka C.
    Acharya, Geeta
    Crasta, Julian
    DIAGNOSTIC CYTOPATHOLOGY, 2025, 53 (05) : 246 - 250
  • [43] Risk assessment of cytology findings in cervical cancer screening
    Marquardt, Katrin
    Ziemke, Peter
    Neumann, Konrad
    Kuehn, Wolfgang
    GYNAKOLOGE, 2019, 52 (12): : 937 - 944
  • [44] Human Papillomavirus Prevalence in Paired Urine and Cervical Samples in Women Invited for Cervical Cancer Screening
    Burroni, Elena
    Bonanni, Paolo
    Sani, Cristina
    Lastrucci, Vieri
    Carozzi, Francesca
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (03) : 508 - 515
  • [45] CYTOLOGY AND HPV DNA CERVICAL CANCER SCREENING IN HIV POSITIVE AND HIV NEGATIVE WOMEN
    Snyman, Leon
    Richter, Karin
    Lukhwareni, Azwidowi Azwidowi
    Dreyer, Gerrit J.
    Botha, Matthys
    Van Der Merwe, Frederick
    Visser, Cathy
    Dreyer, Greta
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A186 - A187
  • [46] Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
    Esther Roura
    Thomas Iftner
    José Antonio Vidart
    Susanne Krüger Kjaer
    F Xavier Bosch
    Nubia Muñoz
    Santiago Palacios
    Maria San Martin Rodriguez
    Carmen Morillo
    Laurence Serradell
    Laurence Torcel-Pagnon
    Javier Cortes
    Xavier Castellsagué
    BMC Infectious Diseases, 12
  • [47] Cervical human papillomavirus (HPV) infection in South African women: Implications for HPV screening and vaccine strategies
    Allan, Bruce
    Marais, Dianne J.
    Hoffman, Margaret
    Shapiro, Samuel
    Williamson, Anna-Lise
    JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (02) : 740 - 742
  • [48] Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
    Katki, Hormuzd A.
    Kinney, Walter K.
    Fetterman, Barbara
    Lorey, Thomas
    Poitras, Nancy E.
    Cheung, Li
    Demuth, Franklin
    Schiffman, Mark
    Wacholder, Sholom
    Castle, Philip E.
    LANCET ONCOLOGY, 2011, 12 (07): : 663 - 672
  • [49] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    PLOS ONE, 2015, 10 (03):
  • [50] Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
    Roura, Esther
    Iftner, Thomas
    Antonio Vidart, Jose
    Kjaer, Susanne Kruger
    Xavier Bosch, F.
    Munoz, Nubia
    Palacios, Santiago
    San Martin Rodriguez, Maria
    Morillo, Carmen
    Serradell, Laurence
    Torcel-Pagnon, Laurence
    Cortes, Javier
    Castellsague, Xavier
    BMC INFECTIOUS DISEASES, 2012, 12